ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 043,47
1,21%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adaptimmune Therapeutics PLC (ADAP)

  7. Adaptimmune Therapeutics PLC (ADAP) Actualités

ADAP

Adaptimmune Therapeutics (ADAP)

Adaptimmune Therapeutics PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADAP
DateHeureSourceTitreSymboleSociété
18/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
11/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
30/11/202322h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ADAPAdaptimmune Therapeutics PLC
08/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
10/08/202322h05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADAPAdaptimmune Therapeutics PLC
29/06/202322h54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ADAPAdaptimmune Therapeutics PLC
29/06/202322h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADAPAdaptimmune Therapeutics PLC
01/06/202322h49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADAPAdaptimmune Therapeutics PLC
22/05/202313h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ADAPAdaptimmune Therapeutics PLC
12/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADAPAdaptimmune Therapeutics PLC
21/04/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADAPAdaptimmune Therapeutics PLC
13/04/202314h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADAPAdaptimmune Therapeutics PLC
12/04/202300h33Dow Jones NewsADRs End Higher, Adaptimmune Therapeutics and Alibaba Trade ActivelyNASDAQ:ADAPAdaptimmune Therapeutics PLC
05/04/202322h41Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ADAPAdaptimmune Therapeutics PLC
03/04/202314h01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADAPAdaptimmune Therapeutics PLC
14/02/202322h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADAPAdaptimmune Therapeutics PLC
18/11/202219h55TipRanksAdaptimmune Therapeutics (ADAP) Gets a Buy from Mizuho SecuritiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
10/11/202205h35TipRanksSVB Securities Sticks to Their Hold Rating for Adaptimmune Therapeutics (ADAP)NASDAQ:ADAPAdaptimmune Therapeutics PLC
26/10/202223h55TipRanksMizuho Securities Keeps Their Hold Rating on Adaptimmune Therapeutics (ADAP)NASDAQ:ADAPAdaptimmune Therapeutics PLC
10/09/202200h02Dow Jones NewsADRs End Higher, Argo Blockchain and Adaptimmune Therapeutics Trade ActivelyNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/09/202201h05TipRanksMizuho Securities Sticks to Their Hold Rating for Adaptimmune Therapeutics (ADAP)NASDAQ:ADAPAdaptimmune Therapeutics PLC
05/08/202217h35TipRanksAdaptimmune Therapeutics (ADAP) Receives a Buy from JonesTradingNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/08/202219h15TipRanksAdaptimmune Therapeutics (ADAP) Gets a Hold Rating from Mizuho SecuritiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/07/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADAPAdaptimmune Therapeutics PLC
17/05/202200h25TipRanksMizuho Securities Remains a Hold on Adaptimmune Therapeutics (ADAP)NASDAQ:ADAPAdaptimmune Therapeutics PLC
16/05/202223h00GlobeNewswire Inc.Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCTNASDAQ:ADAPAdaptimmune Therapeutics PLC
09/05/202222h52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADAPAdaptimmune Therapeutics PLC
09/05/202222h36TipRanksAdaptimmune Therapeutics (ADAP) Receives a Hold from SVB SecuritiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
09/05/202220h55TipRanksMizuho Securities Maintains Their Hold Rating on Adaptimmune Therapeutics (ADAP)NASDAQ:ADAPAdaptimmune Therapeutics PLC
09/05/202213h30GlobeNewswire Inc.Adaptimmune Reports First Quarter Financial Results and Business UpdateNASDAQ:ADAPAdaptimmune Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:ADAP

Dernières Valeurs Consultées

BIT
UC4NHE
Unicredit Bank
BIT
S30621
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés